NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Solius Labs

Solius Labs

Private
Bainbridge Island, WashingtonHealthcare & Life Scienceshttps://www.solius.com/

Last Round

Early Stage

VC

May 14, 2026

Total Funding Raised

$83M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Solius Labs is a medical devices company that develops a phototherapy device designed to stimulate the production of vitamin D.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, Consumer Electronics

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS, Government Contracts

AI Layer

Non-AI

Keywords

phototherapy deviceUVB light therapyvitamin D deficiencyvitamin D lampat-home medical devicenarrow spectrum UVBFDA cleared deviceover-the-counter deviceOTC devicelight therapy paneldirect-to-consumerD2Cbiohackingwellness technologyconsumer electronicsphototherapy booth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Solius Labs Comps

Public and private peers based on sector, stage, and business model.

Solius Labs comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Solius Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCMay 14, 2026
Series BMay 12, 2022
Series A ExtensionNov 5, 2021
Series AMay 24, 2021
SeedFeb 20, 2019

Key People

Founding team and executive leadership

Christopher Kiple

Chief Executive Officer

Executive Team

Mike Ukkestad

Chief Operating Officer

Executive Team

Solius Labs Investors

Notable investors and investment history

Solius Labs investors
InvestorRounds
GSR MarketsSeries A Extension
Hanaco VCSeries A, Series B, Seed
Global Founders CapitalSeed
Avon VenturesSeries A, Series B
645 VenturesSeries A
Liberty City VenturesSeries A Extension, Series B
Declaration PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    $23.5M raised in an early stage VC round.

  • Mar 23, 2025

    Grew 20% QoQ, from 25 to 30 employees.

Solius Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Solius Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Solius Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersBainbridge Island, Washington
Employee Range40
Year Founded2011
Last FundingMay 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.